Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-30 @ 6:59 AM
Study NCT ID:
NCT01552434
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2012-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Malignant Neoplasm | View |
| None | Castleman Disease | View |
| None | Digestive System Carcinoma | View |
| None | Erdheim-Chester Disease | View |
| None | Lip and Oral Cavity Carcinoma | View |
| None | Lymphangioleiomyomatosis | View |
| None | Malignant Endocrine Neoplasm | View |
| None | Malignant Female Reproductive System Neoplasm | View |
| None | Malignant Male Reproductive System Neoplasm | View |
| None | Malignant Neoplasm | View |
| None | Malignant Respiratory Tract Neoplasm | View |
| None | Malignant Thoracic Neoplasm | View |
| None | Malignant Urinary System Neoplasm | View |
| None | Mesothelial Neoplasm | View |
| None | Metastatic Malignant Neoplasm | View |
| None | Metastatic Urothelial Carcinoma | View |
| None | Neurofibromatosis Type 2 | View |
| None | Recurrent Adult Soft Tissue Sarcoma | View |
| None | Recurrent Breast Carcinoma | View |
| None | Recurrent Childhood Soft Tissue Sarcoma | View |
| None | Recurrent Digestive System Carcinoma | View |
| None | Recurrent Female Reproductive System Carcinoma | View |
| None | Recurrent Male Reproductive System Carcinoma | View |
| None | Recurrent Malignant Neoplasm | View |
| None | Recurrent Pharyngeal Carcinoma | View |
| None | Recurrent Thyroid Gland Carcinoma | View |
| None | Refractory Malignant Neoplasm | View |
| None | Soft Tissue Neoplasm | View |
| None | Stage III Breast Cancer AJCC v7 | View |
| None | Stage III Pharyngeal Cancer | View |
| None | Stage IIIA Breast Cancer AJCC v7 | View |
| None | Stage IIIB Breast Cancer AJCC v7 | View |
| None | Stage IIIC Breast Cancer AJCC v7 | View |
| None | Stage IV Breast Cancer AJCC v6 and v7 | View |
| None | Stage IV Pharyngeal Cancer | View |
| None | Stage IVA Pharyngeal Cancer | View |
| None | Stage IVB Pharyngeal Cancer | View |
| None | Stage IVC Pharyngeal Cancer | View |
| None | Thyroid Gland Neoplasm | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Erbitux | View |
| None | Temsirolimus | View |
| None | CCI-779 | View |
| None | Torisel | View |
| None | Bevacizumab | View |
| None | Avastin | View |
| None | rhuMAb-VEGF | View |
| None | Anti-VEGF Monoclonal Antibody | View |
| None | Advanced Cancers | View |
| None | Advanced Malignancy | View |
| None | Metastatic | View |
| None | cancer | View |
| None | Cetuximab | View |
| None | C225 | View |
| None | IMC-C225 | View |
| None | Valproic Acid | View |